These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 401022)

  • 1. Further evidence that serotonin is a neurotransmitter involved in the control of prolactin secretion.
    Clemens JA; Sawyer BD; Cerimele B
    Endocrinology; 1977 Mar; 100(3):692-8. PubMed ID: 401022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of serotonin-active drugs on prolactin secretion in male rats.
    Jagiełło-Wójtowicz E; Załuska W; Szponar J; Surmaczyńska B; Wójcicki M; Kleinrok Z
    Pol J Pharmacol Pharm; 1988; 40(1):73-80. PubMed ID: 2467272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the medial and dorsal raphe nuclei mediate serotonergically-induced increases in prolactin release from the pituitary.
    Fessler RG; Deyo SN; Meltzer HY; Miller RJ
    Brain Res; 1984 May; 299(2):231-7. PubMed ID: 6610456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evidence that serotonergic stimulation of prolactin secretion is mediated via the dorsal raphe nucleus.
    Van de Kar LD; Bethea CL
    Neuroendocrinology; 1982 Oct; 35(4):225-30. PubMed ID: 7145018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic stimulation of prolactin release in the young turkey (Meleagris gallopavo).
    Fehrer SC; Silsby JL; El Halawani ME
    Gen Comp Endocrinol; 1983 Dec; 52(3):400-8. PubMed ID: 6230284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of prolactin release by stimulation of presynaptic serotonin autoreceptors.
    Clemens JA; Roush ME
    Life Sci; 1982 Dec; 31(23):2641-6. PubMed ID: 7154858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotoninergic control of prolactin secretion in prepubertal male rats.
    Aguilar E; Ranchal A; Tena-Sempere M; Pinilla L
    Eur J Endocrinol; 1994 Nov; 131(5):547-54. PubMed ID: 7524955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
    Bero LA; Kuhn CM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
    Lipham LB; Booth NH; Jernigan AD; Robbins JD; Hatch RC
    Am J Vet Res; 1986 May; 47(5):1089-91. PubMed ID: 3717731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological evidence of an interaction between serotonergic and dopaminergic neurons in the control of prolactin secretion in male rats.
    Quattrone A; Schettini G; Di Renzo GF; Preziosi P
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):42-9. PubMed ID: 485703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies on the serotoninergic and nonserotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine. Effects of pretreatment with fluoxetine, indalpine, PCPA, and L-tryptophan.
    Van de Kar LD; Urban JH; Richardson KD; Bethea CL
    Neuroendocrinology; 1985 Oct; 41(4):283-8. PubMed ID: 2931613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of evidence that the central serotoninergic system plays a role in the activation of prolactin secretion following inhibition of dopamine synthesis or blockade of dopamine receptors in the male rat.
    Krulich L; Coppings RJ; Giachetti A; McCann SM; Mayfield MA
    Neuroendocrinology; 1980; 30(3):133-8. PubMed ID: 6445044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats.
    Lawson DM; Gala RR
    Endocrinology; 1978 Mar; 102(3):973-81. PubMed ID: 311279
    [No Abstract]   [Full Text] [Related]  

  • 16. Further evidence that prolactin secretion in adult female rats is differently modified after neonatal estrogenization or androgenization: responses to methysergide, quipazine, and pizotifen.
    Collado D; Aguilar E
    Physiol Behav; 1993 Jan; 53(1):161-5. PubMed ID: 8434056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effect of testosterone on the serotoninergic control of prolactin secretion in prepubertal rats.
    Moguilevsky JA; Justo G; Justo S; Szwarcfarb B; Carbone S; Scacchi P
    Neuroendocrinology; 1990 Feb; 51(2):197-201. PubMed ID: 2106098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that serotonin stimulates a prolactin-releasing factor in the rat.
    Garthwaite TL; Hagen TC
    Neuroendocrinology; 1979; 29(3):215-20. PubMed ID: 114870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of naloxone on the secretion of prolactin and corticosterone induced by 5-hydroxytryptophan and a serotonergic agonist, mCPP.
    Preziosi P; Cerrito F; Vacca M
    Life Sci; 1983 May; 32(21):2423-30. PubMed ID: 6602260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin release after 5-hydroxytryptophan treatment requires an intact neurointermediate pituitary lobe.
    Johnston CA; Fagin KD; Alper RH; Negro-Vilar A
    Endocrinology; 1986 Feb; 118(2):805-10. PubMed ID: 2417827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.